Top Markets
Coin of the day
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Classifica tra le azioni #41543
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Prezzo delle azioni
$0.0005
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$16.73K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia ARYx Therapeutics, Inc. (ARYX)

Categoria

Storico del prezzo dell'azione per ARYx Therapeutics, Inc. (ARYX)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $7.86 il 2007-11-01
Storico del prezzo dell'azione di ARYx Therapeutics, Inc. dal 2007 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 0.00%
2024 -35.90%
2023 56.00%
2022 -78.26%
2021 -47.20%
2020 133.23%
2019 15.59%
2018 -55.10%
2017 -15.05%
2016 97.24%
2015 -55.00%
2014 -53.19%
2013 71.35%
2012 -27.90%
2011 -97.10%
2010 -89.43%
2009 24.41%
2008 -72.51%
2007 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$166.24 27.87%
DE
$36.27 22.59%
JP
$227.73 40.40%
CH
$21.37 13.97%
IN